Pharmaceuticals,Marketing,and Society: A New Center of Gravity for Critical Research and Policy

Bulik Beth S . (2021), “The Top 10 Ad Spenders in Big Pharma for 2020,” Fierce Pharma (April 19), https://www.fiercepharma.com/special-report/top-10-ad-spenders-big-pharma-for-2020.

CDC (2022), “CDC Recommends COVID-19 Vaccines for Young Children,” press release (June 18), https://www.cdc.gov/media/releases/2022/s0618-children-vaccine.html.

Di Domenico Giandomenico , Daniel Nunan, and Valentina Pitardi (2022), “Marketplaces of Misinformation: A Study of How Vaccine Misinformation Is Legitimized on Social Media,” Journal of Public Policy & Marketing, 41 (4), 319–35.

FDA (2020), “Accelerated Approval Program,” (October 26), https://www.fda.gov/drugs/information-health-care-professionals-drugs/accelerated-approval-program.

FDA (2021), “FDA Grants Accelerated Approval for Alzheimer’s Drug,” press release (June 7) https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug.

Florida Department of Health (2022), “Provider Alert Pediatric COVID-19 Vaccines,” press release (June 17), https://www.floridahealth.gov/newsroom/2022/06/20220617-provider-alert-pediatric-covid-19-vaccines.prArticle.html.

King Jesse Yencha Christopher Koppenhafer Leslie Madrigal Robert (2022), “A ‘Clear and Conspicuous’ Distraction: Coping with Incongruent Audiovisual Content in Direct-to-Consumer Advertisements,” Journal of Public Policy & Marketing, 41 (4), 353–67.

Morgan Carter Zane Daniel (2022), “Practitioner Perspectives on Key Challenges in Pharmaceutical Marketing and Future Research Opportunities,” Journal of Public Policy & Marketing, 41 (4), 368–82.

Sarkees Matthew E. Fitzgerald M. Paula Lamberton Cait (2021), “The Pandemic Ripple Effect: Understanding Marketing and Public Policy Opportunities in the Pharmaceutical Industry,” Journal of Public Policy & Marketing, 40 (1), 103–04.

Tong Pui Ying Yencha Christopher Ishida Chiharu (2022), “The Role of Social Norms on Direct-to-Physician Pharmaceutical Marketing Payment Acceptance. Journal of Public Policy & Marketing, 41 (4), 336–52.

U.S. Congress (2022), “H.R.6833-Affordable Insulin Now Act,” https://www.congress.gov/bill/117th-congress/house-bill/6833/text?r=1&s=1.

West Virginia Legislature (2018), “West Virginia Opioid Reduction Act,” http://www.wvlegislature.gov/wvcode/code.cfm?chap=16&art=54.

Wilson Anne (2022), “Clouded Motives and Pharmacological Calvinism: How Recreational Use of a Drug Affects Moral Judgments of its Medical Use,” Journal of Public Policy & Marketing, 41 (4), 304–18.